reverses – Lab DB

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Apr 18, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier decision regarding Moderna’s investigational mRNA influenza vaccine (mRNA-1010),…

Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Apr 4, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance on Moderna’s innovative mRNA influenza vaccine candidate,…

Laboratory Automation & Robotics

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

Lana Keisha Mar 27, 2026 0

In a significant development for vaccine innovation and public health, the U.S. Food and Drug Administration (FDA) has reversed its…

Laboratory Automation & Robotics

FDA reverses course, agrees to review Moderna’s mRNA flu vaccine

Lana Keisha Mar 20, 2026 0

The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance, agreeing to review Moderna’s messenger RNA (mRNA)…

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine

FDA reverses course, agrees to review Moderna’s mRNA flu vaccine

YOU MAY HAVE MISSED

Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the Industry

Pharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report Reveals

Analyzing Natural Speech Patterns Provides Crucial Indicators of Brain Health and Executive Function Across the Lifespan

Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability